Cargando…
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086281/ https://www.ncbi.nlm.nih.gov/pubmed/35534054 http://dx.doi.org/10.1136/rmdopen-2022-002203 |
| _version_ | 1784703962316800000 |
|---|---|
| author | Laster, Andrew J Lam, Gordon K Gladue, Heather S Kashif, Ahmad A Siceloff, Erin P Lackey, Virginia D Robertson, Cheryl R Toci, Ashley L Calabrese, Leonard H |
| author_facet | Laster, Andrew J Lam, Gordon K Gladue, Heather S Kashif, Ahmad A Siceloff, Erin P Lackey, Virginia D Robertson, Cheryl R Toci, Ashley L Calabrese, Leonard H |
| author_sort | Laster, Andrew J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9086281 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90862812022-05-11 Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? Laster, Andrew J Lam, Gordon K Gladue, Heather S Kashif, Ahmad A Siceloff, Erin P Lackey, Virginia D Robertson, Cheryl R Toci, Ashley L Calabrese, Leonard H RMD Open Infections BMJ Publishing Group 2022-05-09 /pmc/articles/PMC9086281/ /pubmed/35534054 http://dx.doi.org/10.1136/rmdopen-2022-002203 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Infections Laster, Andrew J Lam, Gordon K Gladue, Heather S Kashif, Ahmad A Siceloff, Erin P Lackey, Virginia D Robertson, Cheryl R Toci, Ashley L Calabrese, Leonard H Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? |
| title | Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? |
| title_full | Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? |
| title_fullStr | Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? |
| title_full_unstemmed | Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? |
| title_short | Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? |
| title_sort | does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the covid-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (aiird)? |
| topic | Infections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086281/ https://www.ncbi.nlm.nih.gov/pubmed/35534054 http://dx.doi.org/10.1136/rmdopen-2022-002203 |
| work_keys_str_mv | AT lasterandrewj doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT lamgordonk doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT gladueheathers doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT kashifahmada doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT sicelofferinp doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT lackeyvirginiad doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT robertsoncherylr doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT tociashleyl doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird AT calabreseleonardh doesanadjustmenttothedosingandtimingofimmunomodulatorydrugsaltertheimmunogenicityofthecovid19vaccinesinpatientswithautoimmuneandinflammatoryrheumaticdiseaseaiird |